Please assess the completion status of the following clinical trial:

Trial Title: Accolade® TMZF® Hip Stem Outcomes Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Patient is a candidate for a primary total hip replacement.~2. Patient has primary diagnosis of osteoarthritis (OA).~3. Male and non-pregnant female patients ages 18 to 90.~4. Patient has signed an Institutional Review Board (IRB) approved, study specific Informed Patient Consent Form.~5. Patient willing and able to comply with postoperative scheduled clinical and radiographic evaluations and rehabilitation.~6. Patient capable of undergoing a pre-op central DXA (dual-energy x-ray absorptiometry) scan for a bone mineral density (BMD) reading.~Exclusion Criteria:~1. Patient has an active infection within the affected hip joint.~2. Patient requires a revision surgery of a previously implanted total hip arthroplasty or hip fusion to the affected joint.~3. Patient who is morbidly obese, Body Mass Index (BMI) \> 40.~4. Patient has a neuromuscular or neurosensory deficiency, which limits ability to evaluate the safety and efficacy of the device.~5. Patient has the following diagnosed systemic diseases: Paget's disease, renal osteodystrophy, lupus erythematosus, rheumatoid arthritis, metabolic bone disease and sickle cell anemia.~6. Patient is immunologically suppressed or receiving chronic steroids more than 30 days. Patients receiving oral or IV steroids within one month of surgery.~7. Patient is a prisoner.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Accolade® TMZF® Hip Stem (Type: OTHER): Accolade® TMZF® Hip Stem Study Device

Based on this trial design, predict the completion outcome and termination type (if applicable).